BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• Business

  NinePoint Medical Appoints Christopher Von Jako, Ph.D., To Chief Executive Officer

  December 4, 2014

   · 

  3 min read
• Drug Development

  Bavarian Nordic Announces First Subject Dosed With Mva-Bn Filo In A Phase 1 Study Investigating A New Prime-Boost Regimen Of Ebola Candidate Vaccines

  December 4, 2014

   · 

  4 min read
• Deals

  Danaher’s Leica Division Closes Devicor Medical Products Buy

  December 4, 2014

   · 

  1 min read
• Drug Development

  University of Michigan To Study GlycoMimetics, Inc.’ GMI-1271 As Potential Treatment For Serious Blood-Clotting Disorder

  December 4, 2014

   · 

  7 min read
• FDA

  FDA Approves Incyte Corporation’s Jakafi For Patients With Polycythemia Vera

  December 4, 2014

   · 

  9 min read
• Biotech Beach

  SetPoint Announces First Trial Of Bioelectronic Therapy To Treat Crohn’s Disease

  December 4, 2014

   · 

  1 min read
• Drug Development

  ZIOPHARM Oncology And Intrexon Present Clinical And Preclinical Data From Immuno-Oncology Programs At AACR Tumor Immunology And Immunotherapy Meeting

  December 4, 2014

   · 

  12 min read
• Business

  Intrexon Announces The Appointment of Peter Emtage, Ph.D., As Vice President, Synthetic Immunology

  December 4, 2014

   · 

  3 min read